We believe SVT-001 provides true hope to prevent the almost inevitable vision loss caused by this devastating condition ...

Stargardt programs address ABCA4 payload constraints via dual-AAV platforms (VG801, AAVB-039) and explore first ...

Key market opportunities lie in AAV gene therapy advancements for hereditary retinal diseases. Future prospects include combination with CRISPR for precise genome editing, novel delivery platforms, ...

Science has added a whole lot more cash to the bank, bringing in an impressive $230 million in its latest raise. | Science ...

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain retinal cells can rewire themselves when vision begins to deteriorate in ...

In this expert perspective from Retina 2026, Ehsan Rahimy, MD, a retina specialist at Palo Alto Medical Foundation, discussed promising advancements in the treatment of retinal diseases.Rahimy said th ...

"Monogenic" diseases, triggered by mutations in just one gene, may actually be more complex than scientists thought.

Newcells provides a reliable and quick in vitro safety and efficacy service for evaluating novel compounds for retinal therapy with complex human retinal organoid or retinal pigment epithelium (RPE) ...

Recent studies hint that subtle shifts in the peripheral retina could flag Alzheimer’s disease years before brain damage or ...